Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
08/05/2010 | US20100197586 Use of secretin and optionally urodilatin as therapeutic agents |
08/05/2010 | US20100197585 Use of a rgd-peptide and/or parathyroid hormone (1-34) as anti-hiv agent |
08/05/2010 | US20100197581 Native gp41 assay |
08/05/2010 | US20100197572 Use of somatostatin-14 as a therapeutic agent |
08/05/2010 | US20100197570 Cyclodepsipeptides with Antineoplastic Activity and Methods of Using to Inhibit Cancer and Microbial Growth |
08/05/2010 | US20100197569 Cross-linked glycopeptide-cephalosporin antibiotics |
08/05/2010 | US20100196636 Indicators for detecting the presence of metabolic byproducts from microorganisms |
08/05/2010 | US20100196516 Treatment of infections by carbon monoxide |
08/05/2010 | US20100196501 Silver-containing foam structure |
08/05/2010 | US20100196495 Delivery of flu antibodies to surfaces in contact with air |
08/05/2010 | US20100196494 Enhanced antimicrobial activity compositions of blends of plant essential oils |
08/05/2010 | US20100196491 contain at least two purified recombinant monkeypox virus proteins or peptides encoded by the open reading frames of the monkeypox ortholog genes M1R, A35R, A29L B6R, and orthologs of these proteins or peptides having 90% identity |
08/05/2010 | US20100196471 Novel tablet dosage form |
08/05/2010 | US20100196462 Method for Manufacturing a Pharmaceutical Form of Oseltamivir Phosphate |
08/05/2010 | US20100196442 Methods for treating open wounds |
08/05/2010 | US20100196435 Materials and methods for delivering compositions to selected tissues |
08/05/2010 | US20100196424 Stabilization of long chain polyunsaturated oils |
08/05/2010 | US20100196422 Novel polypeptides for isolating in vitro and preventing staphyloccocal infections on joint prostheses and other implanted foreign materials |
08/05/2010 | US20100196420 Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs |
08/05/2010 | US20100196410 Streptococcus pneumoniae Antigens and Vaccines |
08/05/2010 | US20100196409 Basb006 polypeptides from neisseria meningitidis and immunogenic compositions thereof |
08/05/2010 | US20100196407 Tick galectin |
08/05/2010 | US20100196397 Five-helix protein |
08/05/2010 | US20100196382 Nontypeable Haemophilus Influenzae Virulence Factors |
08/05/2010 | US20100196380 Babesia Subtilisin |
08/05/2010 | US20100196379 Group B Streptococcus Polypeptides Nucleic Acids and Therapeutic Compositions and Vaccines Thereof |
08/05/2010 | US20100196375 Engineered scFv against Bovine Herpes Virus Type I |
08/05/2010 | US20100196353 Intradermal hpv peptide vaccination |
08/05/2010 | US20100196340 Lactid acid bacteria as priobiotic strains and compositions containing same |
08/05/2010 | US20100196324 Multifunctional cytokines |
08/05/2010 | US20100196321 Compounds |
08/05/2010 | US20100196319 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
08/05/2010 | US20100196316 Cyclosporin analogues for preventing or treating hepatitis c infection |
08/05/2010 | CA2787697A1 Compositions comprising chlamydia antigens |
08/05/2010 | CA2787429A1 A high molecular weight polysaccharide that binds and inhibits virus |
08/05/2010 | CA2750988A1 Tslp promotes immune evasion and persistence of viruses |
08/04/2010 | EP2213752A1 Recombinant Newcastle disease virus RNA expression systems and vaccines |
08/04/2010 | EP2213743A1 Albumin fusion proteins |
08/04/2010 | EP2213742A1 Chimeric antigens for breaking host tolerance to foreign antigens |
08/04/2010 | EP2213737A1 Double-stranded oligonucleotides |
08/04/2010 | EP2213682A1 TSLP promotes immune evasion and persistence of viruses |
08/04/2010 | EP2213650A1 Substituted diphenylamines as inhibitors of reverse transcriptase, process of preparing them and use thereof |
08/04/2010 | EP2213300A1 Composition and method for treating cancer using herpes virus |
08/04/2010 | EP2213298A2 Immunogenic compositions of staphylococcus epidermidis polypeptide and polynucleotide antigens |
08/04/2010 | EP2213292A1 Double-stranded oligonucleotides |
08/04/2010 | EP2212420A2 Use of oligonucleotides with modified bases as antiviral agents |
08/04/2010 | EP2212325A2 2-arylmethylazetidine-carbapenem-3-carboxylic acid ester derivative or its salt, process for the preparation thereof and pharmaceutical composition comprising the same |
08/04/2010 | EP2212324A1 Compounds having antiviral properties |
08/04/2010 | EP2212305A1 Beta-lactone compounds |
08/04/2010 | EP2212298A1 Deuterated etravirine |
08/04/2010 | EP2211883A1 Antibacterial composition comprising salvia extracts |
08/04/2010 | EP2211868A2 Silicate containing compositions and methods of treatment |
08/04/2010 | EP2015759B1 Combination therapy |
08/04/2010 | EP1587539B1 Antimicrobial composition for local use on mucosal membranes and skin |
08/04/2010 | EP1343769B1 Benzoylpyridazines |
08/04/2010 | EP1185660B1 Porcine circovirus vaccine in recombinant poxvirus |
08/04/2010 | EP1032675B1 Attaching substances to micro-organisms |
08/04/2010 | CN1906302B Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS |
08/04/2010 | CN1717494B Beta-1,4-mannobiose-containing composition |
08/04/2010 | CN101796067A Lantibiotic-based compounds having antimicrobial activity |
08/04/2010 | CN101796040A modulators of pharmacokinetic properties of therapeutics |
08/04/2010 | CN101796024A Stereoisomers of tricyclodecan-9-yl-xanthogenate |
08/04/2010 | CN101795713A conjugate purification |
08/04/2010 | CN101795708A Reduction of concomitant infections in pigs by the use of PCV2 antigen |
08/04/2010 | CN101795706A Bordetella parapertussis-containing whole-cell vaccine composition |
08/04/2010 | CN101795688A Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms |
08/04/2010 | CN101795686A Dentifrice compositions for treating xerostomia |
08/04/2010 | CN101792759A Immune co-enhancing molecule prepared by genetic engineering and immunopotentiation application thereof |
08/04/2010 | CN101792745A Expression and purification of influenza virus polymerase PA N-terminal polypeptide and crystal structure thereof |
08/04/2010 | CN101792744A Recombinant baculovirus expressing Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) immunogen gene and preparation method and application thereof |
08/04/2010 | CN101792743A Recombinant baculovirus expressing porcine circovirus type 2 (PCV-2) immunogen gene and preparation method and application thereof |
08/04/2010 | CN101792742A Recombinant baculovirus expressing IBDV (Infectious Bursal Disease Virus) immunogen gene and preparation method and application thereof |
08/04/2010 | CN101792741A Recombinant baculovirus expressing Japanese Encephalitis Virus (JEV) immunogen gene and preparation method and application thereof |
08/04/2010 | CN101792740A Recombinant baculovirus expressing Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) immunogen gene and preparation method and application thereof |
08/04/2010 | CN101792493A Method for preparing spreading hedyotis herb polysaccharide |
08/04/2010 | CN101792491A Recombinant adenovirus HIV vaccine based on multipleseries epi-position and preparation method thereof |
08/04/2010 | CN101792483A Novel peptides as NS3-serine protease inhibitors of hepatitis c virus |
08/04/2010 | CN101792475A CDP-2-glycerol synthesized in gram-positive bacteria and preparation method thereof |
08/04/2010 | CN101792474A Novel AzalomycinF microlide compounds and preparation method thereof and application thereof |
08/04/2010 | CN101792473A Novel ketolide compound and preparation method and application thereof |
08/04/2010 | CN101792443A Fluoro-carbostyril derivative as well as preparation method and application thereof |
08/04/2010 | CN101792437A Tolyltriazole derivatives, preparation method thereof and use thereof |
08/04/2010 | CN101792418A Geldanamycin biosynthetic analog 19-O-glycyl geldana |
08/04/2010 | CN101792375A Sesquiterpene compound in tobacco stems and preparation method and application thereof |
08/04/2010 | CN101791412A Acyclovir-chitosan-stearic acid grafting, synthetic method and application thereof |
08/04/2010 | CN101791410A Preparation and application of conjugate of anti-infective medicament and polysaccharide and medicinal composition thereof |
08/04/2010 | CN101791407A Gentamicin sulfate wrapped in polylactic acid/nano-hydroxyapatite composite microspheres and preparation method thereof |
08/04/2010 | CN101791405A Method for preparing yolk immunoglobulin vaccine for resisting porphyromonas gingivalis |
08/04/2010 | CN101791404A Fish soaking vaccine immunity adjuvant and application and using method thereof |
08/04/2010 | CN101791398A Multivalent canine vaccines against leptospira bratislava and other pathogens |
08/04/2010 | CN101791397A Application of RNase III protein in staphylococcus aureus for preventing and treating staphylococcus aureus infection |
08/04/2010 | CN101791396A Controlled release compositions for interferon based on PEGT/PBT block copolymers |
08/04/2010 | CN101791395A Application of phospholipid scramblase 1 in preparing anti-hepatitis B virus infective medicament |
08/04/2010 | CN101791392A Application of medicinal composition |
08/04/2010 | CN101791378A Traditional Chinese medicine preparation for wound hemostasis, anti-inflammatory and tissue regeneration |
08/04/2010 | CN101791376A Bactericidal haemostatic sticker and preparation method thereof |
08/04/2010 | CN101791373A Compound combined medicine for treating upper respiratory tract infection of poultry and preparation method thereof |
08/04/2010 | CN101791371A Method for preparing saponin by extracting asparagus officinalis L |
08/04/2010 | CN101791361A Vacuum freeze-drying process for retaining medicative active components of traditional Chinese medicine of radix tetrastigme |
08/04/2010 | CN101791356A Chinese medicine for treating herpes zoster |